Marinus Pharma MRNS reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Marinus Pharma missed estimated earnings by 55.88%, reporting an EPS of $-1.06 versus an estimate of $-0.68.
Revenue was down $115 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.33 which was followed by a 16.46% increase in the share price the next day.
To track all earnings releases for Marinus Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.